1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Category Archives: Antibodies

24Oct/11

Chronic Fatigue Syndrome: Study Supports Autoimmune Disease Theory – ABC News

October 24, 2011Monoclonal Anti-CD20 Antibodiesadmin

Daily MailChronic Fatigue Syndrome: Study Supports Autoimmune Disease TheoryABC NewsTwo injections of the cancer drug Rituximab, which suppresses the immune system, relieved chronic fatigue symptoms in 10 of 15 patients several months later, according …

24Oct/11

Weekly Update: Market Volatility Directs to Greater Volumes for NYSE Euronext – Galaxy Stocks

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Weekly Update: Market Volatility Directs to Greater Volumes for NYSE EuronextGalaxy StocksAbbott Laboratories Inc. (NYSE:ABT) on Saturday reported constructive data from a trial to assess an investigational compound called daclizumab high-yield process…

24Oct/11

Abbott, Biogen report MS drug reduced relapse rate – Boston.com

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Abbott, Biogen report MS drug reduced relapse rateBoston.comBiogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing rel…

24Oct/11

Stocks to watch Monday: Mattel, Biogen Idec – MarketWatch

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Stocks to watch Monday: Mattel, Biogen IdecMarketWatchMore good news for Biogen Idec Inc.: The company and Abbott Laboratories Inc. /quotes/zigman/216393/quotes/nls/abt ABT -0.76% on Saturday presented positive data from a trial to evaluate an investig…

24Oct/11

Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement … – The Pharma Letter

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement …The Pharma LetterBiogen and partner Abbott Laboratories (NYSE: ABT) also announced additional results from the SELECT Phase IIb trial, the first of two registrational…

23Oct/11

ECTRIMS: New Biologic Drug Shows Promise in MS – MedPage Today

October 23, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

ECTRIMS: New Biologic Drug Shows Promise in MSMedPage TodayExplain that treatment with daclizumab (Zenapax), an investigational monoclonal antibody drug, cut annualized relapse rates in half among patients with early relapsing-remitting multiple sclero…

23Oct/11

DrumBeat With Silence Charumbira: Dhewa's music legacy lives on – The Zimbabwe Standard

October 23, 2011Monoclonal Anti-CD20 Antibodiesadmin

DrumBeat With Silence Charumbira: Dhewa's music legacy lives onThe Zimbabwe StandardWhen Dhewa died, he had started receiving Rituximab, a cancer drug invented in India. It is one of the latest cancer drugs and is said to be the best. However, when…

23Oct/11

Will Abbott's Split Unlock Shareholder Value? – Seeking Alpha

October 23, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Will Abbott's Split Unlock Shareholder Value?Seeking AlphaDaclizumab, previously approved in Europe to prevent rejection of organ transplants, is in a Phase 3 trial to examine its efficacy as a multiple sclerosis (MS) treatment. Abbott has three co…

22Oct/11

Meet the first child in Britain to benefit from a pioneering kidney transplant … – Daily Mail

October 22, 2011Monoclonal Anti-CD20 Antibodiesadmin

Daily MailMeet the first child in Britain to benefit from a pioneering kidney transplant …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stoppi…

22Oct/11

Nabeel Nanuck kidney transplant: 1st child in Britain that didn't require a … – Daily Mail

October 22, 2011Monoclonal Anti-CD20 Antibodiesadmin

Daily MailNabeel Nanuck kidney transplant: 1st child in Britain that didn't require a …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stopp…

Posts navigation

  • « Previous
  • 1
  • …
  • 273
  • 274
  • 275
  • 276
  • 277
  • …
  • 281
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos